The United States (US) Center for Disease Control and Prevention (CDC) estimated that at the end of 2006, there were 1,106,400 adults and adolescents infected with HIV. The HIV epidemic has changed drastically since its initial recognition. There has been significant progress in both treatment and prognosis since the HIV epidemic began three decades ago. What was once acute inpatient care of the dying has become outpatient chronic disease management with equal or greater focus on other co-morbidities.
The HIV Medicine Association (HIVMA) and the American Academy of HIV Medicine (AAHIVM) issued a joint statement in 2009 confirming their belief that a workforce shortage is imminent. Training PCPs to care for patients with chronic HIV infection may allow us to better meet the chronic health care needs of this growing population.
It is well documented that PCPs as well as NPs and PAs experienced at caring for patients with HIV provide quality of care equal to that of ID specialists. However, research has shown that only 67% of residents in primary care fields felt prepared to care for patients with HIV and AIDS. HIVMA and AAHIVM have both defined criteria for HIV specialiststs that includes a certification exam, providing care to at least twenty HIV patients, and ongoing CME in the area of HIV. These criteria suggest that PCPs can function as primary providers of HIV care with additional training and interest in this area short of an ID fellowship.
Moreover, the literature suggests that: there are may be emerging or existing patterns of racial disparities in healthcare and treatment of patients with HIV; race- and ethnicity-based discrimination within the healthcare environment are associated with disparities in care; and that such discrimination is associated with both worse chronic health condition control and a higher incidence catastrophic health events.
This free online CME program has been designed to bring healthcare professionals’ knowledge of and competence in the treatment and management of HIV and bridge the existing gaps preventing them from administering care to the HIV population.
Agenda
Introduction, Disclosures
Epidemiology of and risk factors for HIV
• Statistics – snapshots and trends
• Genotype
• Racial/ethnic disparities
Transmission, Pathogenesis, and Diagnosis of HIV
• Onset
• Risk factors, modifiable and non-
• Initial and chronic symptomology, constitutional and organ-system specific
• Viral load and CD4 count vs. AIDS-defining illnesses
• Patient cases
Treatment of HIV/AIDS
• Latest evidence supporting when to start therapy
• Evolution and present recommendations from the NIH guidelines in both treatment-experienced and treatment-naïve patients
• Role of resistance testing
• Recent advances in therapy, pharmacologic and non-
• How comorbid conditions, diseases, and opportunistic impact therapeutic considerations of the primary infection
• Best practice: putting it all together
• Patient cases
Barriers to optimal care in patients with HIV
• Adherence to therapy
• Modifiable risk factors
• Patient case(s)
Summary, conclusions, and best practice recap
Healthcare professionals specializing in: family practice, HIV/AIDS, internal medicine, infectious diseases, preventive medicine, public health, and other clinicians who commonly treat patients with HIV/AIDS.
Commercial Support Disclosure: This program is supported by educational grants from Bristol-Meyers-Squibb.
Release Date: March 08, 2013 -- Expiration Date: March 08, 2015
Faculty: Sarah Wieczorkiewicz, PharmD
By the end of the session the participant will be able to:
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
As an provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is our policy to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review by ScientiaCME.
Faculty Disclosure: Sarah Wieczorkiewicz, PharmD reports that she has no disclosures.
Disclosures of Educational Planner: Charles Turck, PharmD is an officer and part owner of ScientiaCME, LLC. ScientiaCME has received grants from the commercial supporter of this program.
Commercial Support Disclosure: This program is supported by educational grants from Bristol-Meyers-Squibb.
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.